The industry continues to face financial and regulatory headwinds, including high interest rates and uncertainty about ...

Jay Rosanelli, CEO at Syenex, added: "This joint effort showcases the role of collaborative science in accelerating the ...

Financial technology and capital markets firm Clear Street launched its healthcare and biotechnology equity research last month ...

Arjan van Manen joins BioLizard as Commercial Director, bringing over 20 years of commercial leadership experience in life sciencesMeet ...

J.P. Morgan releases its annual look-ahead days before the entire biopharma industry descends on San Francisco for the annual ...

GAINESVILLE, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) -- X-tosis, Inc., a pre-clinical biotech company transforming the treatment ...

M&A didn’t return as hoped for in 2024. The biopharma industry is heading into the J.P. Morgan Healthcare Conference next ...

I welcome the opportunity of sharing novel information about our company and the secreted form of the Klotho anti-aging gene, 's-KL', the patent protected development platform on which our product ...

CHICAGO and PARK CITY, UT - January 5, 2025 - Contact Carnivores, a leading healthcare communications firm, is proud to announce its 10th consecutive year participating in the JP Morgan Healthcare ...

GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

AI Proteins, Inc., a pioneering company utilizing artificial intelligence to design novel protein therapeutics, announces the appointment of its founder, President and Chief Scientific Officer, Dr.